Pharmaceutical Industry Information Portal

HomeNews

News

FDA approves Bristol Myers’ Opdualag cancer immunotherapy

Bristol Myers Squibb announced that OpdualagTM, a new, first-in-class, fixed-dose combination of nivolumab and relatlimab, administered as a single intravenous infusion, was approved by...

Roche offers molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants

Roche and TIB Molbiol, a subsidiary within the Roche Diagnostics division, announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate...

Emmes makes 4th acquisition in CRO focused on rare diseases

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced that it has acquired...

Alnylam Pharmaceuticals files patent infringement suits against Moderna, Pfizer

Alnylam Pharmaceuticals, Inc. announced that it has separately filed suit in United States District Court for the District of Delaware against Pfizer, Inc. and...

RedHill signs deal with Kukbo for oral COVID-19 drug in South Korea

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that it has entered into an exclusive license agreement with Kukbo Co. Ltd., a South Korean...

Pandemic Antiviral Discovery initiative created by the Novo Nordisk Foundation, Open Philanthropy and the Gates Foundation

Global initiative will accelerate the discovery and development of antiviral drug candidates that can be distributed quickly and equitably next time the world faces...
spot_img

Expert Articles

spot_img